The estimated Net Worth of Dinesh C Paliwal is at least $1.32 million dollars as of 29 October 2020. Mr. Paliwal owns over 9,532 units of Bristol-Myers Squibb Co stock worth over $969,176 and over the last 11 years he sold BMY stock worth over $0. In addition, he makes $353,846 as Independent Director at Bristol-Myers Squibb Co.
Dinesh has made over 5 trades of the Bristol-Myers Squibb Co stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 9,532 units of BMY stock worth $499,572 on 29 October 2020.
The largest trade he's ever made was buying 9,532 units of Bristol-Myers Squibb Co stock on 29 October 2020 worth over $499,572. On average, Dinesh trades about 474 units every 29 days since 2013. As of 29 October 2020 he still owns at least 19,946 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Mr. Paliwal stock trades at the bottom of the page.
Dinesh C. Paliwal serves as Independent Director of the Company. Mr. Paliwal has served as President and Chief Executive Officer at Harman International, the connected technologies company for automotive, consumer and enterprise markets since 2007. Mr. Paliwal also served as Chairman of the Harman Board of Directors from July 2008 until March 2017 until its acquisition by Samsung Electronics Co., Ltd. Today, Harman operates as a wholly-owned subsidiary of Samsung. Prior to joining Harman, Mr. Paliwal served as a member of the Group Executive Committee of ABB Ltd., a provider of industrial automation, power transmission systems and services from January 2001 until June 2007. He also served as President of Global Markets and Technology of ABB Ltd. from January 2006 until June 2007, as Chairman and Chief Executive Officer of ABB North America from January 2004 until June 2007, and as President and Chief Executive Officer of ABB Automation Technologies Division from October 2002 until December 2005. Mr. Paliwal is a member of the CEO Business Roundtable and the advisory board of the Woodrow Wilson Center. He also serves on the Boards of Directors of the Business Advisory Council of Farmer School of Business, Miami University of Ohio and the U.S. Indian Business Council. During the last five years, Mr. Paliwal was a Director of ADT Corporation.
As the Independent Director of Bristol-Myers Squibb Co, the total compensation of Dinesh Paliwal at Bristol-Myers Squibb Co is $353,846. There are 14 executives at Bristol-Myers Squibb Co getting paid more, with Giovanni Caforio having the highest compensation of $18,767,300.
Dinesh Paliwal is 62, he's been the Independent Director of Bristol-Myers Squibb Co since 2013. There are 6 older and 28 younger executives at Bristol-Myers Squibb Co. The oldest executive at Bristol-Myers Squibb Co. is Vicki Sato, 71, who is the Lead Independent Director.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius et Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: